

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | extracellular fibril organization (GO:0043206) | 5.28686443 |
| 2 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.91158779 |
| 3 | blood vessel maturation (GO:0001955) | 4.40460603 |
| 4 | fibril organization (GO:0097435) | 4.35855150 |
| 5 | collagen fibril organization (GO:0030199) | 4.34434431 |
| 6 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.33839777 |
| 7 | desmosome organization (GO:0002934) | 4.25041697 |
| 8 | protein heterotrimerization (GO:0070208) | 4.12130791 |
| 9 | endodermal cell differentiation (GO:0035987) | 3.96875511 |
| 10 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.96079438 |
| 11 | vocalization behavior (GO:0071625) | 3.82008870 |
| 12 | negative regulation of protein localization to cell surface (GO:2000009) | 3.71393724 |
| 13 | cell migration involved in heart development (GO:0060973) | 3.59043247 |
| 14 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.57641583 |
| 15 | extracellular matrix assembly (GO:0085029) | 3.55487804 |
| 16 | dermatan sulfate biosynthetic process (GO:0030208) | 3.55096150 |
| 17 | cell adhesion mediated by integrin (GO:0033627) | 3.51491033 |
| 18 | kidney mesenchyme development (GO:0072074) | 3.49514637 |
| 19 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.40477070 |
| 20 | metanephric mesenchyme development (GO:0072075) | 3.39966354 |
| 21 | dermatan sulfate metabolic process (GO:0030205) | 3.38354726 |
| 22 | substrate-dependent cell migration (GO:0006929) | 3.33206699 |
| 23 | sprouting angiogenesis (GO:0002040) | 3.32496058 |
| 24 | cellular response to vitamin (GO:0071295) | 3.31247114 |
| 25 | endothelium development (GO:0003158) | 3.29554673 |
| 26 | protein localization to cell surface (GO:0034394) | 3.26603747 |
| 27 | substrate adhesion-dependent cell spreading (GO:0034446) | 3.22760649 |
| 28 | extracellular regulation of signal transduction (GO:1900115) | 3.21727323 |
| 29 | extracellular negative regulation of signal transduction (GO:1900116) | 3.21727323 |
| 30 | negative regulation of complement activation (GO:0045916) | 3.19627946 |
| 31 | glomerular basement membrane development (GO:0032836) | 3.19620217 |
| 32 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.19340583 |
| 33 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.09754822 |
| 34 | chondrocyte proliferation (GO:0035988) | 3.07063881 |
| 35 | endocardial cushion development (GO:0003197) | 3.06997232 |
| 36 | sphingoid metabolic process (GO:0046519) | 3.05978431 |
| 37 | glutamate secretion (GO:0014047) | 3.05870233 |
| 38 | bone trabecula formation (GO:0060346) | 3.04972891 |
| 39 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.03414788 |
| 40 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.99311989 |
| 41 | positive regulation of fibroblast migration (GO:0010763) | 2.98317261 |
| 42 | pericardium development (GO:0060039) | 2.97773581 |
| 43 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.97577123 |
| 44 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.96761250 |
| 45 | axon extension involved in axon guidance (GO:0048846) | 2.96761250 |
| 46 | positive regulation of vesicle fusion (GO:0031340) | 2.96480702 |
| 47 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.94432571 |
| 48 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.94060039 |
| 49 | positive regulation of synapse assembly (GO:0051965) | 2.90829183 |
| 50 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.90752282 |
| 51 | protein localization to synapse (GO:0035418) | 2.89966219 |
| 52 | artery development (GO:0060840) | 2.87130420 |
| 53 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.86243168 |
| 54 | glutamate receptor signaling pathway (GO:0007215) | 2.86167256 |
| 55 | negative chemotaxis (GO:0050919) | 2.86151702 |
| 56 | cellular response to vitamin D (GO:0071305) | 2.84138156 |
| 57 | presynaptic membrane assembly (GO:0097105) | 2.83974893 |
| 58 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.79789333 |
| 59 | transferrin transport (GO:0033572) | 2.79314514 |
| 60 | induction of positive chemotaxis (GO:0050930) | 2.77946357 |
| 61 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.77704012 |
| 62 | skin morphogenesis (GO:0043589) | 2.76606405 |
| 63 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.74342949 |
| 64 | multicellular organismal catabolic process (GO:0044243) | 2.73822330 |
| 65 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.71944297 |
| 66 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.71944297 |
| 67 | neuron cell-cell adhesion (GO:0007158) | 2.70415144 |
| 68 | trivalent inorganic cation transport (GO:0072512) | 2.69880917 |
| 69 | ferric iron transport (GO:0015682) | 2.69880917 |
| 70 | virion attachment to host cell (GO:0019062) | 2.68192543 |
| 71 | adhesion of symbiont to host cell (GO:0044650) | 2.68192543 |
| 72 | neural crest cell development (GO:0014032) | 2.68143328 |
| 73 | multicellular organismal metabolic process (GO:0044236) | 2.67792971 |
| 74 | cranial suture morphogenesis (GO:0060363) | 2.67011072 |
| 75 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.65529904 |
| 76 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.63748363 |
| 77 | synaptic vesicle exocytosis (GO:0016079) | 2.63335560 |
| 78 | presynaptic membrane organization (GO:0097090) | 2.63036711 |
| 79 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.62528767 |
| 80 | molting cycle (GO:0042303) | 2.62393663 |
| 81 | hair cycle (GO:0042633) | 2.62393663 |
| 82 | negative regulation of platelet activation (GO:0010544) | 2.61747299 |
| 83 | angiogenesis involved in wound healing (GO:0060055) | 2.61516667 |
| 84 | extracellular matrix disassembly (GO:0022617) | 2.61200199 |
| 85 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.59264941 |
| 86 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.58895751 |
| 87 | negative regulation of stem cell proliferation (GO:2000647) | 2.58710513 |
| 88 | long-term synaptic potentiation (GO:0060291) | 2.58630017 |
| 89 | fibroblast migration (GO:0010761) | 2.57404560 |
| 90 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.56957497 |
| 91 | negative regulation of cartilage development (GO:0061037) | 2.56519185 |
| 92 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.55308956 |
| 93 | endothelial cell proliferation (GO:0001935) | 2.54653414 |
| 94 | positive regulation of vasculogenesis (GO:2001214) | 2.54480746 |
| 95 | craniofacial suture morphogenesis (GO:0097094) | 2.53772453 |
| 96 | gonadal mesoderm development (GO:0007506) | 2.53753266 |
| 97 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.52824156 |
| 98 | membrane assembly (GO:0071709) | 2.52654869 |
| 99 | regulation of gonadotropin secretion (GO:0032276) | 2.52314349 |
| 100 | cell-matrix adhesion (GO:0007160) | 2.51734472 |
| 101 | smooth muscle tissue development (GO:0048745) | 2.51525309 |
| 102 | regulation of sarcomere organization (GO:0060297) | 2.50987017 |
| 103 | type B pancreatic cell proliferation (GO:0044342) | 2.50983211 |
| 104 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.50944018 |
| 105 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.50420031 |
| 106 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.49391651 |
| 107 | neuron-neuron synaptic transmission (GO:0007270) | 2.48877484 |
| 108 | response to gravity (GO:0009629) | 2.48783701 |
| 109 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.48494762 |
| 110 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.48485165 |
| 111 | behavioral response to cocaine (GO:0048148) | 2.46638401 |
| 112 | collagen metabolic process (GO:0032963) | 2.46593457 |
| 113 | cell-substrate adhesion (GO:0031589) | 2.46511853 |
| 114 | negative regulation of protein activation cascade (GO:2000258) | 2.46164764 |
| 115 | synaptic transmission, glutamatergic (GO:0035249) | 2.46072876 |
| 116 | negative regulation of BMP signaling pathway (GO:0030514) | 2.45552501 |
| 117 | chondrocyte development (GO:0002063) | 2.45344130 |
| 118 | negative regulation of adherens junction organization (GO:1903392) | 2.44906239 |
| 119 | negative regulation of focal adhesion assembly (GO:0051895) | 2.44906239 |
| 120 | negative regulation of cell junction assembly (GO:1901889) | 2.44906239 |
| 121 | regulation of lipoprotein metabolic process (GO:0050746) | 2.44575330 |
| 122 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.43878591 |
| 123 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.43499067 |
| 124 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.43424690 |
| 125 | regulation of chondrocyte differentiation (GO:0032330) | 2.43411636 |
| 126 | collagen catabolic process (GO:0030574) | 2.43133586 |
| 127 | positive regulation of cartilage development (GO:0061036) | 2.43003647 |
| 128 | tonic smooth muscle contraction (GO:0014820) | 2.42877604 |
| 129 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.42341436 |
| 130 | positive regulation of endothelial cell migration (GO:0010595) | 2.42325607 |
| 131 | regulation of glutamate secretion (GO:0014048) | 2.42030069 |
| 132 | mesodermal cell differentiation (GO:0048333) | 2.41712219 |
| 133 | cell proliferation involved in kidney development (GO:0072111) | 2.41585754 |
| 134 | cardiac myofibril assembly (GO:0055003) | 2.41394502 |
| 135 | regulation of fibroblast migration (GO:0010762) | 2.41189574 |
| 136 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.41077644 |
| 137 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.40880324 |
| 138 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.40605382 |
| 139 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.40605382 |
| 140 | basement membrane organization (GO:0071711) | 2.40405406 |
| 141 | regulation of hippo signaling (GO:0035330) | 2.39385882 |
| 142 | regulation of cartilage development (GO:0061035) | 2.39349712 |
| 143 | wound healing, spreading of epidermal cells (GO:0035313) | 2.39054807 |
| 144 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.38258275 |
| 145 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.37615109 |
| 146 | postsynaptic membrane organization (GO:0001941) | 2.36112904 |
| 147 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.35718741 |
| 148 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.35120669 |
| 149 | peptide cross-linking (GO:0018149) | 2.34130241 |
| 150 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.33294857 |
| 151 | lymphangiogenesis (GO:0001946) | 2.32934443 |
| 152 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.31614883 |
| 153 | neuron recognition (GO:0008038) | 2.31284379 |
| 154 | extracellular matrix organization (GO:0030198) | 2.29067705 |
| 155 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.28515183 |
| 156 | extracellular structure organization (GO:0043062) | 2.28066576 |
| 157 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.27146165 |
| 158 | regulation of synapse assembly (GO:0051963) | 2.25958258 |
| 159 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.25807702 |
| 160 | protein localization to cilium (GO:0061512) | 2.25768186 |
| 161 | peptidyl-proline hydroxylation (GO:0019511) | 2.25266920 |
| 162 | regulation of vesicle fusion (GO:0031338) | 2.24861420 |
| 163 | positive regulation of muscle hypertrophy (GO:0014742) | 2.24775624 |
| 164 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.24775624 |
| 165 | ephrin receptor signaling pathway (GO:0048013) | 2.23575217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.74487707 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.64448927 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.90799147 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.79261825 |
| 5 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.68253386 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.64980789 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.64097343 |
| 8 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.57924348 |
| 9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.56152316 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46193180 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46193180 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.37663265 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.36425681 |
| 14 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.35636640 |
| 15 | TP53_18474530_ChIP-ChIP_U2OS_Human | 2.33449786 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.21673328 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.19021204 |
| 18 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.16188535 |
| 19 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.11033313 |
| 20 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.07524029 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.03792940 |
| 22 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.02210524 |
| 23 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.00149595 |
| 24 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.00149595 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.95384893 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91572812 |
| 27 | CJUN_26792858_Chip-Seq_BT549_Human | 1.91045164 |
| 28 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.88055097 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.85669670 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.85072141 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.81103053 |
| 32 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.80061146 |
| 33 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.79356904 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.73750754 |
| 35 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.73340966 |
| 36 | P300_19829295_ChIP-Seq_ESCs_Human | 1.72134223 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.71198738 |
| 38 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.68266049 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65547991 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.64194906 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63965167 |
| 42 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.63743029 |
| 43 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.62979028 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.61935008 |
| 45 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.61430222 |
| 46 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.61049813 |
| 47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.58843278 |
| 48 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58213509 |
| 49 | TP53_16413492_ChIP-PET_HCT116_Human | 1.56011724 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.52989744 |
| 51 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.51983207 |
| 52 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.51818534 |
| 53 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.49882297 |
| 54 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48269879 |
| 55 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.47883324 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47090538 |
| 57 | FUS_26573619_Chip-Seq_HEK293_Human | 1.46180092 |
| 58 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.45899371 |
| 59 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.45472037 |
| 60 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.44407625 |
| 61 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.43623284 |
| 62 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42421720 |
| 63 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39601939 |
| 64 | STAT3_23295773_ChIP-Seq_U87_Human | 1.38926829 |
| 65 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36471747 |
| 66 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.35104343 |
| 67 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.35039701 |
| 68 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34498600 |
| 69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34454312 |
| 70 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34368694 |
| 71 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33273600 |
| 72 | VDR_22108803_ChIP-Seq_LS180_Human | 1.33000353 |
| 73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32659595 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.31539454 |
| 75 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28783590 |
| 76 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28006030 |
| 77 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27243473 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 1.25654892 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.25319283 |
| 80 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24328096 |
| 81 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23739178 |
| 82 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23588654 |
| 83 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.21972123 |
| 84 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.21932869 |
| 85 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21404112 |
| 86 | KDM2B_26808549_Chip-Seq_REH_Human | 1.18130133 |
| 87 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.17965287 |
| 88 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17081193 |
| 89 | TCF4_23295773_ChIP-Seq_U87_Human | 1.15686368 |
| 90 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.14908838 |
| 91 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12702040 |
| 92 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.11808350 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11532048 |
| 94 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10827599 |
| 95 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.10390810 |
| 96 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.10189637 |
| 97 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10002736 |
| 98 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09834275 |
| 99 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08434686 |
| 100 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.08309099 |
| 101 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06809172 |
| 102 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06599007 |
| 103 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06096520 |
| 104 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.05881964 |
| 105 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.04283938 |
| 106 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.04000428 |
| 107 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.03735703 |
| 108 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.03541633 |
| 109 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03178922 |
| 110 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02901199 |
| 111 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.02458716 |
| 112 | JUN_21703547_ChIP-Seq_K562_Human | 1.02287315 |
| 113 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.01661620 |
| 114 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00991947 |
| 115 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00991947 |
| 116 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.00982924 |
| 117 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00793093 |
| 118 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98125741 |
| 119 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.97677206 |
| 120 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95658456 |
| 121 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95121860 |
| 122 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94599439 |
| 123 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.94442531 |
| 124 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94188097 |
| 125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.93851896 |
| 126 | EWS_26573619_Chip-Seq_HEK293_Human | 0.92474875 |
| 127 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91150123 |
| 128 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.90435550 |
| 129 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.89516321 |
| 130 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87703612 |
| 131 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.87498271 |
| 132 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.87320172 |
| 133 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87099871 |
| 134 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86821235 |
| 135 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.84641933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 7.05879287 |
| 2 | MP0005275_abnormal_skin_tensile | 5.48563449 |
| 3 | MP0005503_abnormal_tendon_morphology | 5.28037071 |
| 4 | MP0001958_emphysema | 3.30347052 |
| 5 | MP0003279_aneurysm | 3.05278733 |
| 6 | MP0003880_abnormal_central_pattern | 2.86568817 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.83863098 |
| 8 | MP0010386_abnormal_urinary_bladder | 2.75866395 |
| 9 | MP0002009_preneoplasia | 2.74387503 |
| 10 | MP0009384_cardiac_valve_regurgitation | 2.55612231 |
| 11 | MP0003941_abnormal_skin_development | 2.51469967 |
| 12 | MP0004859_abnormal_synaptic_plasticity | 2.43830415 |
| 13 | MP0002060_abnormal_skin_morphology | 2.17273780 |
| 14 | MP0002295_abnormal_pulmonary_circulatio | 2.08721300 |
| 15 | MP0006054_spinal_hemorrhage | 2.04819435 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.04035717 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 1.96995201 |
| 18 | MP0004084_abnormal_cardiac_muscle | 1.90713046 |
| 19 | MP0005623_abnormal_meninges_morphology | 1.87963253 |
| 20 | MP0001542_abnormal_bone_strength | 1.80352209 |
| 21 | MP0001968_abnormal_touch/_nociception | 1.80121961 |
| 22 | MP0002736_abnormal_nociception_after | 1.79042919 |
| 23 | MP0004272_abnormal_basement_membrane | 1.75222342 |
| 24 | MP0002108_abnormal_muscle_morphology | 1.72700407 |
| 25 | MP0005508_abnormal_skeleton_morphology | 1.69550005 |
| 26 | MP0005171_absent_coat_pigmentation | 1.69253763 |
| 27 | MP0000516_abnormal_urinary_system | 1.61757204 |
| 28 | MP0005367_renal/urinary_system_phenotyp | 1.61757204 |
| 29 | MP0003635_abnormal_synaptic_transmissio | 1.52030838 |
| 30 | MP0000569_abnormal_digit_pigmentation | 1.46442955 |
| 31 | MP0005595_abnormal_vascular_smooth | 1.45643473 |
| 32 | MP0003385_abnormal_body_wall | 1.44458728 |
| 33 | MP0002282_abnormal_trachea_morphology | 1.39244273 |
| 34 | MP0001243_abnormal_dermal_layer | 1.37611443 |
| 35 | MP0009046_muscle_twitch | 1.35870736 |
| 36 | MP0002249_abnormal_larynx_morphology | 1.35582519 |
| 37 | MP0004883_abnormal_blood_vessel | 1.32770033 |
| 38 | MP0002063_abnormal_learning/memory/cond | 1.32548348 |
| 39 | MP0004036_abnormal_muscle_relaxation | 1.32448083 |
| 40 | MP0009745_abnormal_behavioral_response | 1.31977316 |
| 41 | MP0003566_abnormal_cell_adhesion | 1.30391390 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.29884961 |
| 43 | MP0001879_abnormal_lymphatic_vessel | 1.27018496 |
| 44 | MP0010368_abnormal_lymphatic_system | 1.25744451 |
| 45 | MP0003045_fibrosis | 1.25655456 |
| 46 | MP0002796_impaired_skin_barrier | 1.25088645 |
| 47 | MP0003828_pulmonary_edema | 1.24640829 |
| 48 | MP0009053_abnormal_anal_canal | 1.23523439 |
| 49 | MP0002735_abnormal_chemical_nociception | 1.21362068 |
| 50 | MP0010771_integument_phenotype | 1.20199923 |
| 51 | MP0002168_other_aberrant_phenotype | 1.18302320 |
| 52 | MP0005257_abnormal_intraocular_pressure | 1.17842770 |
| 53 | MP0008004_abnormal_stomach_pH | 1.15968555 |
| 54 | MP0001299_abnormal_eye_distance/ | 1.14825931 |
| 55 | MP0008775_abnormal_heart_ventricle | 1.13580988 |
| 56 | MP0002064_seizures | 1.10145785 |
| 57 | MP0000534_abnormal_ureter_morphology | 1.08468525 |
| 58 | MP0002128_abnormal_blood_circulation | 1.08285934 |
| 59 | MP0004145_abnormal_muscle_electrophysio | 1.06305634 |
| 60 | MP0002572_abnormal_emotion/affect_behav | 1.04635446 |
| 61 | MP0002896_abnormal_bone_mineralization | 1.03760189 |
| 62 | MP0001501_abnormal_sleep_pattern | 1.00969048 |
| 63 | MP0000749_muscle_degeneration | 1.00848787 |
| 64 | MP0000751_myopathy | 0.99486057 |
| 65 | MP0009250_abnormal_appendicular_skeleto | 0.98896125 |
| 66 | MP0005164_abnormal_response_to | 0.98301065 |
| 67 | MP0004484_altered_response_of | 0.98082966 |
| 68 | MP0001177_atelectasis | 0.96495287 |
| 69 | MP0005023_abnormal_wound_healing | 0.96045226 |
| 70 | MP0004270_analgesia | 0.95632378 |
| 71 | MP0005670_abnormal_white_adipose | 0.94089100 |
| 72 | MP0004215_abnormal_myocardial_fiber | 0.93981770 |
| 73 | MP0004858_abnormal_nervous_system | 0.91674787 |
| 74 | MP0000537_abnormal_urethra_morphology | 0.90656444 |
| 75 | MP0001188_hyperpigmentation | 0.90572526 |
| 76 | MP0002822_catalepsy | 0.89095852 |
| 77 | MP0003122_maternal_imprinting | 0.89069143 |
| 78 | MP0001440_abnormal_grooming_behavior | 0.88762210 |
| 79 | MP0000759_abnormal_skeletal_muscle | 0.87342277 |
| 80 | MP0001614_abnormal_blood_vessel | 0.85555665 |
| 81 | MP0005388_respiratory_system_phenotype | 0.84879523 |
| 82 | MP0002133_abnormal_respiratory_system | 0.84879523 |
| 83 | MP0000767_abnormal_smooth_muscle | 0.84739890 |
| 84 | MP0002272_abnormal_nervous_system | 0.84529476 |
| 85 | MP0005390_skeleton_phenotype | 0.83932195 |
| 86 | MP0005165_increased_susceptibility_to | 0.83714294 |
| 87 | MP0001346_abnormal_lacrimal_gland | 0.82618377 |
| 88 | MP0006276_abnormal_autonomic_nervous | 0.82340800 |
| 89 | MP0003091_abnormal_cell_migration | 0.80622209 |
| 90 | MP0000762_abnormal_tongue_morphology | 0.78409264 |
| 91 | MP0001661_extended_life_span | 0.78297799 |
| 92 | MP0000163_abnormal_cartilage_morphology | 0.77774493 |
| 93 | MP0002127_abnormal_cardiovascular_syste | 0.77191870 |
| 94 | MP0001984_abnormal_olfaction | 0.77093390 |
| 95 | MP0009379_abnormal_foot_pigmentation | 0.76489337 |
| 96 | MP0002734_abnormal_mechanical_nocicepti | 0.76183906 |
| 97 | MP0000343_altered_response_to | 0.75914413 |
| 98 | MP0005464_abnormal_platelet_physiology | 0.75838350 |
| 99 | MP0000538_abnormal_urinary_bladder | 0.75158712 |
| 100 | MP0002972_abnormal_cardiac_muscle | 0.75068764 |
| 101 | MP0000733_abnormal_muscle_development | 0.74139109 |
| 102 | MP0003942_abnormal_urinary_system | 0.74126225 |
| 103 | MP0004130_abnormal_muscle_cell | 0.73718596 |
| 104 | MP0005369_muscle_phenotype | 0.73690519 |
| 105 | MP0000427_abnormal_hair_cycle | 0.73262073 |
| 106 | MP0000778_abnormal_nervous_system | 0.71761400 |
| 107 | MP0000249_abnormal_blood_vessel | 0.71123166 |
| 108 | MP0000750_abnormal_muscle_regeneration | 0.69609705 |
| 109 | MP0005620_abnormal_muscle_contractility | 0.69244350 |
| 110 | MP0010352_gastrointestinal_tract_polyps | 0.68847189 |
| 111 | MP0000647_abnormal_sebaceous_gland | 0.68114239 |
| 112 | MP0010030_abnormal_orbit_morphology | 0.67998784 |
| 113 | MP0000428_abnormal_craniofacial_morphol | 0.67968427 |
| 114 | MP0002184_abnormal_innervation | 0.67459336 |
| 115 | MP0006138_congestive_heart_failure | 0.67342906 |
| 116 | MP0003315_abnormal_perineum_morphology | 0.66505321 |
| 117 | MP0002332_abnormal_exercise_endurance | 0.65811088 |
| 118 | MP0002733_abnormal_thermal_nociception | 0.65680988 |
| 119 | MP0003755_abnormal_palate_morphology | 0.65499813 |
| 120 | MP0000049_abnormal_middle_ear | 0.65209292 |
| 121 | MP0001544_abnormal_cardiovascular_syste | 0.64417226 |
| 122 | MP0005385_cardiovascular_system_phenoty | 0.64417226 |
| 123 | MP0002876_abnormal_thyroid_physiology | 0.64225805 |
| 124 | MP0002933_joint_inflammation | 0.63855295 |
| 125 | MP0001970_abnormal_pain_threshold | 0.62505624 |
| 126 | MP0002925_abnormal_cardiovascular_devel | 0.62201766 |
| 127 | MP0000579_abnormal_nail_morphology | 0.62068653 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.61841851 |
| 129 | MP0004085_abnormal_heartbeat | 0.61824983 |
| 130 | MP0005451_abnormal_body_composition | 0.61564316 |
| 131 | MP0003252_abnormal_bile_duct | 0.61514595 |
| 132 | MP0005501_abnormal_skin_physiology | 0.60742203 |
| 133 | MP0002163_abnormal_gland_morphology | 0.60357158 |
| 134 | MP0002115_abnormal_skeleton_extremities | 0.60185475 |
| 135 | MP0005395_other_phenotype | 0.59925483 |
| 136 | MP0009697_abnormal_copulation | 0.59204755 |
| 137 | MP0002067_abnormal_sensory_capabilities | 0.58609373 |
| 138 | MP0004134_abnormal_chest_morphology | 0.58494518 |
| 139 | MP0003448_altered_tumor_morphology | 0.58002303 |
| 140 | MP0003283_abnormal_digestive_organ | 0.57436714 |
| 141 | MP0003950_abnormal_plasma_membrane | 0.57431819 |
| 142 | MP0004087_abnormal_muscle_fiber | 0.56875263 |
| 143 | MP0002102_abnormal_ear_morphology | 0.56321792 |
| 144 | MP0005084_abnormal_gallbladder_morpholo | 0.55948130 |
| 145 | MP0005187_abnormal_penis_morphology | 0.55227294 |
| 146 | MP0002106_abnormal_muscle_physiology | 0.51997608 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 6.70667799 |
| 2 | Aortic aneurysm (HP:0004942) | 5.93423779 |
| 3 | Premature rupture of membranes (HP:0001788) | 5.85244316 |
| 4 | Vascular tortuosity (HP:0004948) | 5.50498913 |
| 5 | Bladder diverticulum (HP:0000015) | 3.89450243 |
| 6 | Aortic dissection (HP:0002647) | 3.89430629 |
| 7 | Soft skin (HP:0000977) | 3.84513856 |
| 8 | Focal motor seizures (HP:0011153) | 3.76056293 |
| 9 | Dilatation of the ascending aorta (HP:0005111) | 3.70799429 |
| 10 | Abnormality of dentin (HP:0010299) | 3.67687877 |
| 11 | Wormian bones (HP:0002645) | 3.59816274 |
| 12 | Atrophic scars (HP:0001075) | 3.58846410 |
| 13 | Spondylolisthesis (HP:0003302) | 3.49372539 |
| 14 | Vertebral compression fractures (HP:0002953) | 3.47693791 |
| 15 | Follicular hyperkeratosis (HP:0007502) | 3.44425910 |
| 16 | Overgrowth (HP:0001548) | 3.21887030 |
| 17 | Fragile skin (HP:0001030) | 3.17537219 |
| 18 | Increased corneal curvature (HP:0100692) | 3.16964589 |
| 19 | Keratoconus (HP:0000563) | 3.16964589 |
| 20 | Wrist flexion contracture (HP:0001239) | 3.09295376 |
| 21 | Aortic regurgitation (HP:0001659) | 2.94887709 |
| 22 | Broad metatarsal (HP:0001783) | 2.92221184 |
| 23 | Mitral valve prolapse (HP:0001634) | 2.91888068 |
| 24 | Arterial tortuosity (HP:0005116) | 2.91841490 |
| 25 | Ulnar claw (HP:0001178) | 2.91550764 |
| 26 | Pulmonary artery stenosis (HP:0004415) | 2.87437290 |
| 27 | Peritonitis (HP:0002586) | 2.84598232 |
| 28 | Neonatal short-limb short stature (HP:0008921) | 2.81060097 |
| 29 | Epileptic encephalopathy (HP:0200134) | 2.74858057 |
| 30 | Redundant skin (HP:0001582) | 2.70588955 |
| 31 | Focal seizures (HP:0007359) | 2.69942415 |
| 32 | Increased mean platelet volume (HP:0011877) | 2.69431031 |
| 33 | Blue sclerae (HP:0000592) | 2.69052997 |
| 34 | Biconcave vertebral bodies (HP:0004586) | 2.68212365 |
| 35 | Alopecia of scalp (HP:0002293) | 2.67370799 |
| 36 | Mitral stenosis (HP:0001718) | 2.66793642 |
| 37 | Bowel diverticulosis (HP:0005222) | 2.64818316 |
| 38 | Shallow orbits (HP:0000586) | 2.64460892 |
| 39 | Spinal rigidity (HP:0003306) | 2.61575060 |
| 40 | Abnormal delivery (HP:0001787) | 2.60407051 |
| 41 | Atelectasis (HP:0100750) | 2.59793058 |
| 42 | Mesomelia (HP:0003027) | 2.55858424 |
| 43 | Testicular atrophy (HP:0000029) | 2.55819316 |
| 44 | Ankle contracture (HP:0006466) | 2.52214289 |
| 45 | Menorrhagia (HP:0000132) | 2.51040232 |
| 46 | Broad ribs (HP:0000885) | 2.49321957 |
| 47 | Distal lower limb amyotrophy (HP:0008944) | 2.48976136 |
| 48 | Hyperextensible skin (HP:0000974) | 2.48554095 |
| 49 | Absence seizures (HP:0002121) | 2.47686588 |
| 50 | Atonic seizures (HP:0010819) | 2.47458272 |
| 51 | Hyperventilation (HP:0002883) | 2.41601652 |
| 52 | Narrow nasal bridge (HP:0000446) | 2.41508915 |
| 53 | Cerebral aneurysm (HP:0004944) | 2.39117370 |
| 54 | Type 1 muscle fiber predominance (HP:0003803) | 2.36601481 |
| 55 | Ectopia lentis (HP:0001083) | 2.36173006 |
| 56 | Mitral regurgitation (HP:0001653) | 2.36163656 |
| 57 | Corneal dystrophy (HP:0001131) | 2.34792252 |
| 58 | Right ventricular cardiomyopathy (HP:0011663) | 2.33691706 |
| 59 | Bradycardia (HP:0001662) | 2.27874134 |
| 60 | Aortic valve stenosis (HP:0001650) | 2.23767717 |
| 61 | Abnormal platelet volume (HP:0011876) | 2.23347926 |
| 62 | Genu recurvatum (HP:0002816) | 2.20132132 |
| 63 | Slender build (HP:0001533) | 2.18526373 |
| 64 | Spontaneous hematomas (HP:0007420) | 2.17867557 |
| 65 | Striae distensae (HP:0001065) | 2.16033245 |
| 66 | Limited hip movement (HP:0008800) | 2.14010888 |
| 67 | Palpebral edema (HP:0100540) | 2.13612592 |
| 68 | Premature skin wrinkling (HP:0100678) | 2.11997913 |
| 69 | Distal lower limb muscle weakness (HP:0009053) | 2.10321482 |
| 70 | Dialeptic seizures (HP:0011146) | 2.10098510 |
| 71 | Hip contracture (HP:0003273) | 2.09627986 |
| 72 | Abnormality of the calf musculature (HP:0001430) | 2.09008443 |
| 73 | Nemaline bodies (HP:0003798) | 2.07211088 |
| 74 | Venous insufficiency (HP:0005293) | 2.07092996 |
| 75 | Nonimmune hydrops fetalis (HP:0001790) | 2.07011433 |
| 76 | Abnormality of the acetabulum (HP:0003170) | 2.05550720 |
| 77 | Cardiovascular calcification (HP:0011915) | 2.05110294 |
| 78 | Calf muscle hypertrophy (HP:0008981) | 2.03604443 |
| 79 | Increased connective tissue (HP:0009025) | 2.02558734 |
| 80 | Lower limb amyotrophy (HP:0007210) | 2.00521573 |
| 81 | Parakeratosis (HP:0001036) | 2.00248896 |
| 82 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.99728685 |
| 83 | Morphological abnormality of the middle ear (HP:0008609) | 1.97790833 |
| 84 | Increased variability in muscle fiber diameter (HP:0003557) | 1.96227210 |
| 85 | Aneurysm (HP:0002617) | 1.92215810 |
| 86 | Generalized tonic-clonic seizures (HP:0002069) | 1.92171752 |
| 87 | Hypotrichosis (HP:0001006) | 1.90712300 |
| 88 | Joint laxity (HP:0001388) | 1.89858578 |
| 89 | Cervical subluxation (HP:0003308) | 1.89782865 |
| 90 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.89030818 |
| 91 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.88783085 |
| 92 | Osteolytic defects of the hand bones (HP:0009699) | 1.88783085 |
| 93 | Amblyopia (HP:0000646) | 1.86220628 |
| 94 | Elbow flexion contracture (HP:0002987) | 1.85920840 |
| 95 | Ovoid vertebral bodies (HP:0003300) | 1.85808921 |
| 96 | Muscle fiber inclusion bodies (HP:0100299) | 1.84301862 |
| 97 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.81532805 |
| 98 | Coronal craniosynostosis (HP:0004440) | 1.80571866 |
| 99 | Venous abnormality (HP:0002624) | 1.80231146 |
| 100 | Conjunctival telangiectasia (HP:0000524) | 1.79784125 |
| 101 | Spontaneous abortion (HP:0005268) | 1.79117086 |
| 102 | Steppage gait (HP:0003376) | 1.78822138 |
| 103 | Natal tooth (HP:0000695) | 1.78285969 |
| 104 | Bruising susceptibility (HP:0000978) | 1.76808071 |
| 105 | Abnormality of the anterior chamber (HP:0000593) | 1.76704616 |
| 106 | Knee flexion contracture (HP:0006380) | 1.76491478 |
| 107 | Osteopenia (HP:0000938) | 1.76250160 |
| 108 | Short hallux (HP:0010109) | 1.76113624 |
| 109 | Joint stiffness (HP:0001387) | 1.75237766 |
| 110 | Hypoplasia of the iris (HP:0007676) | 1.74770110 |
| 111 | Camptodactyly of toe (HP:0001836) | 1.73146907 |
| 112 | Bulbous nose (HP:0000414) | 1.72043715 |
| 113 | Round ear (HP:0100830) | 1.71628043 |
| 114 | Abnormality of proline metabolism (HP:0010907) | 1.71251004 |
| 115 | Hydroxyprolinuria (HP:0003080) | 1.71251004 |
| 116 | Mild short stature (HP:0003502) | 1.70727231 |
| 117 | Absent frontal sinuses (HP:0002688) | 1.70593734 |
| 118 | Upper limb muscle weakness (HP:0003484) | 1.70326370 |
| 119 | Osteoarthritis (HP:0002758) | 1.70204956 |
| 120 | Lipoatrophy (HP:0100578) | 1.69788623 |
| 121 | Metaphyseal dysplasia (HP:0100255) | 1.68319918 |
| 122 | Portal hypertension (HP:0001409) | 1.66914138 |
| 123 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.66593070 |
| 124 | Buphthalmos (HP:0000557) | 1.66076845 |
| 125 | Hematochezia (HP:0002573) | 1.65879314 |
| 126 | Pulmonic stenosis (HP:0001642) | 1.65767703 |
| 127 | Hypoventilation (HP:0002791) | 1.65074594 |
| 128 | Facial diplegia (HP:0001349) | 1.64457520 |
| 129 | Heterochromia iridis (HP:0001100) | 1.64360060 |
| 130 | Protruding ear (HP:0000411) | 1.63991566 |
| 131 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.63929170 |
| 132 | Wide anterior fontanel (HP:0000260) | 1.63886765 |
| 133 | Delayed gross motor development (HP:0002194) | 1.62897746 |
| 134 | Coxa vara (HP:0002812) | 1.62810469 |
| 135 | Erythema (HP:0010783) | 1.62160876 |
| 136 | Insidious onset (HP:0003587) | 1.61445863 |
| 137 | Termporal pattern (HP:0011008) | 1.61445863 |
| 138 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.61325101 |
| 139 | Infantile muscular hypotonia (HP:0008947) | 1.61277884 |
| 140 | Progressive cerebellar ataxia (HP:0002073) | 1.61030965 |
| 141 | Hypoplastic ischia (HP:0003175) | 1.60876606 |
| 142 | Cerebral inclusion bodies (HP:0100314) | 1.60199476 |
| 143 | Full cheeks (HP:0000293) | 1.59897372 |
| 144 | Recurrent corneal erosions (HP:0000495) | 1.59887835 |
| 145 | Inguinal hernia (HP:0000023) | 1.57188827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.11216857 |
| 2 | TIE1 | 4.17090047 |
| 3 | MAP3K12 | 3.40789749 |
| 4 | RIPK4 | 3.37730638 |
| 5 | EPHA4 | 3.13853256 |
| 6 | LATS2 | 2.98029303 |
| 7 | TGFBR2 | 2.93056451 |
| 8 | PLK2 | 2.92830392 |
| 9 | FER | 2.71709036 |
| 10 | NTRK3 | 2.67229585 |
| 11 | MYLK | 2.61289303 |
| 12 | EPHA3 | 2.55892681 |
| 13 | BMPR2 | 2.44267069 |
| 14 | NEK9 | 2.42832819 |
| 15 | BCR | 2.12328465 |
| 16 | PIM2 | 2.03575556 |
| 17 | FRK | 1.98512904 |
| 18 | ARAF | 1.95605508 |
| 19 | MUSK | 1.95372755 |
| 20 | ZAK | 1.76982151 |
| 21 | ERBB3 | 1.68461041 |
| 22 | STK3 | 1.68336245 |
| 23 | MAP2K7 | 1.59057350 |
| 24 | PTK2B | 1.58998367 |
| 25 | PDGFRA | 1.56121806 |
| 26 | STK38L | 1.54476389 |
| 27 | TGFBR1 | 1.53501585 |
| 28 | AKT3 | 1.52087270 |
| 29 | MINK1 | 1.51313283 |
| 30 | KIT | 1.50471741 |
| 31 | NUAK1 | 1.50124875 |
| 32 | PRPF4B | 1.48108371 |
| 33 | DAPK1 | 1.45107081 |
| 34 | TAOK2 | 1.43804095 |
| 35 | MAP3K4 | 1.40904526 |
| 36 | PDK2 | 1.40755037 |
| 37 | SIK3 | 1.40713018 |
| 38 | TNK2 | 1.40589632 |
| 39 | PTK2 | 1.40212701 |
| 40 | DDR2 | 1.37707302 |
| 41 | NTRK1 | 1.33856260 |
| 42 | LATS1 | 1.32764315 |
| 43 | EPHB2 | 1.26661148 |
| 44 | PDK4 | 1.26151260 |
| 45 | PDK3 | 1.26151260 |
| 46 | TRPM7 | 1.25560809 |
| 47 | PIK3CA | 1.25171562 |
| 48 | DAPK2 | 1.18910339 |
| 49 | MAP2K4 | 1.14399330 |
| 50 | GRK1 | 1.12463288 |
| 51 | FLT3 | 1.12302203 |
| 52 | ILK | 1.09810547 |
| 53 | TEC | 1.04407261 |
| 54 | PRKG2 | 1.02532064 |
| 55 | PAK3 | 1.01258395 |
| 56 | PRKCE | 0.98631357 |
| 57 | GRK5 | 0.97400468 |
| 58 | TESK1 | 0.97059817 |
| 59 | OBSCN | 0.93789678 |
| 60 | CDK19 | 0.92027770 |
| 61 | PRKCG | 0.90401713 |
| 62 | KDR | 0.87969605 |
| 63 | CAMK2A | 0.86568265 |
| 64 | MAPK7 | 0.86546023 |
| 65 | ACVR1B | 0.85585906 |
| 66 | DAPK3 | 0.84902556 |
| 67 | PRKD2 | 0.83770185 |
| 68 | MARK1 | 0.82193780 |
| 69 | BRAF | 0.80551083 |
| 70 | MAP2K1 | 0.80322451 |
| 71 | LIMK1 | 0.80188050 |
| 72 | DMPK | 0.77094379 |
| 73 | INSRR | 0.76564846 |
| 74 | ERBB4 | 0.76004207 |
| 75 | TTN | 0.73915783 |
| 76 | KSR1 | 0.72223165 |
| 77 | PIK3CG | 0.71336933 |
| 78 | NEK6 | 0.68284603 |
| 79 | RAF1 | 0.66479081 |
| 80 | MAP3K13 | 0.66143558 |
| 81 | CDK5 | 0.64270280 |
| 82 | MELK | 0.61193433 |
| 83 | SIK2 | 0.60505770 |
| 84 | ADRBK1 | 0.60376556 |
| 85 | MAP3K9 | 0.60202340 |
| 86 | MAP3K7 | 0.59937944 |
| 87 | FGFR2 | 0.57429754 |
| 88 | ROCK1 | 0.57308616 |
| 89 | PRKD1 | 0.55438288 |
| 90 | SGK2 | 0.54816879 |
| 91 | CDK14 | 0.54523507 |
| 92 | MAPK13 | 0.53847847 |
| 93 | PAK6 | 0.52900810 |
| 94 | PRKAA2 | 0.51958161 |
| 95 | NLK | 0.50467997 |
| 96 | BRSK2 | 0.48527765 |
| 97 | CDK18 | 0.47936976 |
| 98 | ABL1 | 0.47724472 |
| 99 | STK39 | 0.47399889 |
| 100 | MAP3K5 | 0.46474512 |
| 101 | CAMK2B | 0.45804344 |
| 102 | BMX | 0.44639721 |
| 103 | CDC42BPA | 0.44567226 |
| 104 | YES1 | 0.42977634 |
| 105 | PLK3 | 0.42696431 |
| 106 | OXSR1 | 0.42094921 |
| 107 | FGR | 0.41465338 |
| 108 | GSK3A | 0.41411097 |
| 109 | PKN1 | 0.41356842 |
| 110 | ROCK2 | 0.40528053 |
| 111 | JAK1 | 0.39873452 |
| 112 | CDK15 | 0.38555762 |
| 113 | DYRK1A | 0.38128235 |
| 114 | PAK4 | 0.38073300 |
| 115 | MAP3K3 | 0.37909529 |
| 116 | ADRBK2 | 0.37743245 |
| 117 | MAP3K2 | 0.37694765 |
| 118 | NME1 | 0.37070137 |
| 119 | CDK8 | 0.36019571 |
| 120 | INSR | 0.35767861 |
| 121 | MAP3K6 | 0.35289115 |
| 122 | STK38 | 0.34971578 |
| 123 | PAK1 | 0.34737737 |
| 124 | PAK2 | 0.33863865 |
| 125 | ABL2 | 0.33360547 |
| 126 | PINK1 | 0.32380909 |
| 127 | MAPKAPK3 | 0.32206998 |
| 128 | PNCK | 0.31946107 |
| 129 | PDGFRB | 0.31437260 |
| 130 | MET | 0.30982832 |
| 131 | CAMK2G | 0.30774883 |
| 132 | GRK7 | 0.30767657 |
| 133 | EIF2AK3 | 0.30733361 |
| 134 | MOS | 0.30400758 |
| 135 | PRKG1 | 0.29011309 |
| 136 | IGF1R | 0.28896303 |
| 137 | PRKCH | 0.28063661 |
| 138 | SGK494 | 0.27447159 |
| 139 | SGK223 | 0.27447159 |
| 140 | WNK1 | 0.27363108 |
| 141 | STK16 | 0.27129932 |
| 142 | CAMK1 | 0.26662477 |
| 143 | CDK11A | 0.25973519 |
| 144 | MAPK12 | 0.25733902 |
| 145 | PRKACA | 0.25133545 |
| 146 | PRKCZ | 0.25044279 |
| 147 | BMPR1B | 0.24970180 |
| 148 | MAPKAPK5 | 0.22442720 |
| 149 | PRKD3 | 0.21240646 |
| 150 | MAP4K2 | 0.20797277 |
| 151 | SRC | 0.19617588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.91047883 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.84216445 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.35842235 |
| 4 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.22092257 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.15262863 |
| 6 | Platelet activation_Homo sapiens_hsa04611 | 2.08595081 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.03726547 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.02369109 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.00776493 |
| 10 | Renin secretion_Homo sapiens_hsa04924 | 1.79502252 |
| 11 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.78490099 |
| 12 | Olfactory transduction_Homo sapiens_hsa04740 | 1.76604701 |
| 13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.75092881 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.72046048 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.66889379 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.65726928 |
| 17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.59907515 |
| 18 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.58188804 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.58035527 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.58010129 |
| 21 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.56606261 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.55105950 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.53297328 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.51902777 |
| 25 | GABAergic synapse_Homo sapiens_hsa04727 | 1.48693250 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.48135259 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.47167558 |
| 28 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.46755602 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.42516819 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.39784365 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.39494919 |
| 32 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.37094619 |
| 33 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.33453219 |
| 34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.30753026 |
| 35 | Focal adhesion_Homo sapiens_hsa04510 | 1.30543990 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.29725893 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.27239919 |
| 38 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.26652531 |
| 39 | Axon guidance_Homo sapiens_hsa04360 | 1.24625324 |
| 40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.19522944 |
| 41 | Melanoma_Homo sapiens_hsa05218 | 1.16999658 |
| 42 | Gap junction_Homo sapiens_hsa04540 | 1.15463705 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14542815 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.14461708 |
| 45 | Glioma_Homo sapiens_hsa05214 | 1.12947924 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.12019046 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 1.11063382 |
| 48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.08614358 |
| 49 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.08267535 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 1.06735066 |
| 51 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.05581537 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.04410030 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01438877 |
| 54 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.00130231 |
| 55 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.00106548 |
| 56 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.98182255 |
| 57 | Insulin secretion_Homo sapiens_hsa04911 | 0.98143081 |
| 58 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95743737 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.95531726 |
| 60 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.93989553 |
| 61 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.93753456 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.93194352 |
| 63 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.92666427 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92657941 |
| 65 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.92357089 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92293246 |
| 67 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91409917 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90412179 |
| 69 | Phototransduction_Homo sapiens_hsa04744 | 0.90297061 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89989766 |
| 71 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.89713940 |
| 72 | Cocaine addiction_Homo sapiens_hsa05030 | 0.89348867 |
| 73 | Pathways in cancer_Homo sapiens_hsa05200 | 0.87854586 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.85308787 |
| 75 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.84751757 |
| 76 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.84637662 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.84625039 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.82426550 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82330946 |
| 80 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79809510 |
| 81 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78866671 |
| 82 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.78805458 |
| 83 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78680592 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.77462060 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76643266 |
| 86 | Adherens junction_Homo sapiens_hsa04520 | 0.76510484 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76160476 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76153152 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74987591 |
| 90 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.74355982 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.73920225 |
| 92 | Malaria_Homo sapiens_hsa05144 | 0.73694432 |
| 93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.72286951 |
| 94 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72103990 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70692238 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70361691 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70209863 |
| 98 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70067714 |
| 99 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.69894700 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69394757 |
| 101 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.68727098 |
| 102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68723583 |
| 103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68102083 |
| 104 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.67586683 |
| 105 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64369972 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63489328 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62883295 |
| 108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.62736956 |
| 109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62725849 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62250932 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.61295854 |
| 112 | Huntingtons disease_Homo sapiens_hsa05016 | 0.61212176 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61017701 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58910186 |
| 115 | Mineral absorption_Homo sapiens_hsa04978 | 0.58768108 |
| 116 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.57972513 |
| 117 | Bladder cancer_Homo sapiens_hsa05219 | 0.57884770 |
| 118 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53903718 |
| 119 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50254229 |
| 120 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.48029726 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47939847 |
| 122 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47794567 |
| 123 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46400704 |
| 124 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.44627223 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44324238 |
| 126 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.42782742 |
| 127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42764782 |
| 128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40678826 |
| 129 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.39455970 |
| 130 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39438738 |
| 131 | Salmonella infection_Homo sapiens_hsa05132 | 0.38800261 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38216418 |
| 133 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37451794 |
| 134 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36416022 |
| 135 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36159057 |
| 136 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.36016378 |
| 137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35974595 |
| 138 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35504086 |
| 139 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34782245 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.34408251 |
| 141 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33004412 |

